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Introduction: Bepridil is a multi-ion channel blocker similar to amiodarone. Recent
clinical studies have indicated that bepridil shows a favorable eﬃcacy for the treatment of
atrial ﬁbrillation (AF). The purpose of this study is to evaluate the eﬀectiveness of bepridil for
electrical remodeling induced by rapid atrial stimulation particularly in the acute-phase.
Methods and Results:We studied 18 pigs subjected to right atrial appendage rapid pacing
at 500 beats/min for 3 hours that were randomly assigned to the absence or presence of
bepridil administration for 14 days. They were divided into 2 groups, an atrial pacing only
group (PG; n ¼ 10) and an atrial pacing plus bepridil group (PBG; n ¼ 8). We measured the
eﬀective refractory period (ERP) at the right atrial free wall (RAFW), the right atrial
appendage (RAA) and the left atrial free wall (LAFW), as well as the monophasic action
potential duration at 90% (MAPD90) in RAA during the rapid pacing phase and recovery
phase.
In the PG, the ERP decreased gradually at all atrial sites during the 3 hour phase of rapid
pacing. In contrast, the shortening of the ERP was suppressed signiﬁcantly at the RAFW and
LAFW in the PBG. The MAPD90 was also shortened by rapid atrial pacing in the PG. This
shortening was suppressed signiﬁcantly in the PBG.
We evaluated the eﬀect of bepridil on the inducibility of AF during all time spans. The
mean number of AF occurrences in the PBG was signiﬁcantly fewer than in the PG.
(2:1 2:4 vs. 8:5 7:0, p < 0:05)
Conclusions: Bepridil prevented the shortening of the ERP and MAPD90 induced by rapid
atrial pacing in the acute phase. The results of this study might explain the eﬃcacy of bepridil
for preventing the recurrence of paroxysmal AF.
(J Arrhythmia 2009; 25: 89–94)
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Introduction
Atrial ﬁbrillation (AF) is one of the most common
arrhythmias and increases the risk of ischemic
stroke.1) Previous studies have suggested that AF
produces the electrophysiological remodeling which
is characterized by shortening of the eﬀective
refractory period (ERP) of the atrium.2,3) It is known
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that electrophysiological remodeling plays an im-
portant role in inducibility and persistence of AF.
Recent studies reported that statin, prednisone and
amiodarone prevented electrical remodeling of the
atrium on pacing-induced AF animal models.4–6)
Bepridil hydrochloride has multiple ion-channel
blocking eﬀects similar to amiodarone and is useful
for persistent AF conversion and maintenance of
sinus rhythm.7) It has been reported to suppress atrial
ERP shortening in continuous rapid pacing during
the subacute to chronic phase. The purpose of this
study is to evaluate the eﬀectiveness of bepridil for
electrical remodeling induced by rapid atrial stim-
ulation in the acute-phase.
Methods
All experiments were performed in accordance
with guidelines for animal research in our institute.
Eighteen female pigs weighting 26:6 2:9 kg were
randomly divided into 2 groups, an atrial pacing only
group (PG; n ¼ 10) and an atrial pacing plus bepridil
group (PBG; n ¼ 8). The pigs in the PBG were
administered oral bepridil 200mg/day starting 2
weeks before pacing.
All pigs were sedated with intravascular ketamine
hydrochloride and anesthetized with intravenous
sodium pentobarbital. Room air was mechanically
ventilated.
After midline thoracotomy, pairs of needle
electrodes were attached to the right atrial free
wall (RAFW) and left atrial free wall (LAFW). To
record the monophasic action potential duration at
90% (MAPD90), a contact electrode catheter (MAP
catheter 1675P Boston Scientiﬁc) was inserted into
the right atrial appendage (RAA) through the right
internal jugular vein. For continuous atrial rapid
pacing, a screw-in pacing lead connected to a
generator (customized Thera SR, Medtronic) was
ﬁxed on the epicardium of the right atrial append-
age (Figure 1). About one hour after the induction
of anesthesia, baseline electrophysiological study
was performed. The output for stimulation was set
at twice the diastolic threshold. Atrial ERP was
measured at the RAFW, LAFW and RAA by
applying eight basic stimuli (S1) at cycle length of
400ms followed by one premature stimulus (S2).
The S2 coupling interval was shortened in 5-ms
steps and the atrial ERP was deﬁned as the longest
S1-S2 interval that failed to capture the atria. The
MAPD90 was measured at a cycle length of
400ms.
In each group, rapid atrial pacing at 500 beats per
minute was continued for 180 minutes. Every 30
minutes an electrophysiological study was repeated
to record the atrial ERP and MAPD90 changes. To
measure the AF inducibility we counted the number
of AF occurrences during extra-stimulation. AF was
deﬁned as a rapid irregular electrogram lasting >1
second.
Statistical Analysis
All data were presented as a mean SD. Dif-
ferences between groups were evaluated by paired
Student’s t-test. A two-tailed P value less than
0.05 was taken to indicate statistical signiﬁcance.
ANOVA for repeated measures was used to
compare the eﬀects of rapid atrial pacing in each
region.
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Figure 1 Schematic positions of the atrial
electrodes.
RAFW: right atrial free wall, LAFW: left atrial free
wall, SVC: superior vena cava, IVC: inferior vena
cava, PV: pulmonary vein
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Results
We measured PR and RR intervals, QRS duration
and QT, as well as the QTc interval in ECGs at
baseline. Although the PR intervals and QRS
duration were not signiﬁcantly diﬀerent among the
two groups, the RR intervals, QT, and QTc interval
were signiﬁcantly prolonged in the PBG (499:4
42:5 vs 618:1 116:5ms; P < 0:05, 280:0 28:2 vs
359:4 41:8ms, 395:8 34:4 vs 465:0 34:3ms;
P < 0:01). There were no adverse eﬀects including
torsade de pointes (Tdp) due to QT intervals
prolongation.
In the PBG, the mean plasma concentration of
bepridil was 193:4 265:7 ng/ml.
Effects of Bepridil on Atrial ERP and MAPD90
Figure 2 compares the regional ERPs before atrial
rapid pacing. The ERP was longer in the PBG than
the PG, but only the RAA showed a signiﬁcant
increase in PBG (PG, 194:8 27:5ms; PBG
227:3 22:6ms; P < 0:05). Serial ERP changes
during atrial rapid pacing and recovery period are
shown in Figure 3(A–C). In both groups, the atrial
ERP decreased gradually by rapid pacing temporally
and recovered eventually to nearly the pre-rapid
pacing state in the recovery period.
Bepridil prolonged atrial ERP in all time courses
signiﬁcantly in the RAFW and LAFW (P < 0:05).
Figure 4 shows the eﬀects of rapid pacing and
bepridil after 180 minutes on the ERP in diﬀerent
regions. Rapid pacing decreased atrial ERPs in all
regions signiﬁcantly. However, in the presence of
bepridil, atrial ERPs were signiﬁcantly prolonged.
Similar temporal changes were observed in
MAPD90 (Figure 5). MAPD90 values were shortened
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Figure 2 Eﬀect of bepridil on baseline ERP.
Only the RAA showed a signiﬁcant increase in PBG (PG, 194:8
27:5ms; PBG 227:3 22:6ms; P < 0:05).
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Figure 3 (A, B, C) Eﬀect of bepridil on serial ERP changes
during rapid pacing and recovery period.
In both groups, the atrial ERP decreased gradually by rapid pacing
temporally and recovered quickly in the recovery period. Bepridil
prolonged atrial ERP in all time spans signiﬁcantly in the RAFW
and LAFW (P < 0:05).
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during atrial rapid pacing and they recovered
immediately after stopping pacing in both groups.
In the presence of bepridil, the values of MAPD90
remained signiﬁcantly longer (P < 0:01).
AF Inducibility
Figure 6 shows the incidence of AF in both groups
in all time spans. The mean number of AF
occurrences in the PBG was signiﬁcantly fewer than
in the PG. (2:1 2:4 vs. 8:5 7:0, p < 0:05)
Discussion
Major Findings
The major ﬁnding of this study is that bepridil
pretreatment attenuated the shortening of ERP or
MAPD90 values caused by short-term atrial rapid
pacing in the acute phase. This study shows rapid
atrial pacing leads to electrical remodeling that
occurs inhomogeneously.
Mechanisms of Atrial Electrical Remodeling in
the Acute Phase
Many studies have reported the atrial electro-
physiological remodeling caused by rapid pacing in
animal AF models during various periods.5,8–10) We
found that rapid pacing increases the inducibility
of AF and shortening of the ERP and MAPD90 even
in the acute phase and bepridil attenuated these
phenomena.
It has been well established that Ca2þ currents
play an important role in atrial electrical remodeling.
The shortening of atrial ERP due to tachycardia was
considered to be the result of a signiﬁcant reduction
of the density of L-type Ca2þ current (ICaL) in the
acute phase.11–14) The ICaL blocker verapamil and
diltiazem prevent this alteration. Whereas the selec-
tive T-type Ca2þ current (ICaT) blocker mibefradil
reduces atrial remodeling in the mid-to-late
phase.8,9,11,15) According to some studies, bepridil
blocks both ICaL and ICaT. Especially, bepridil has a
concentration-dependent strong ICaL blocking ef-
fect.16–19) Nishida et al. reported the eﬃcacy of
bepridil against the expression of L-type calcium
channel 1c messenger ribonucleic acid (mRNA)
after 6 weeks of rapid atrial pacing.16) 1c mRNA
expression was decreased in only the rapid pacing
group. By using bepridil, it was maintained signiﬁ-
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Figure 4 Eﬀect of rapid pacing and bepridil on ERP in
diﬀerent atrial regions.
Rapid pacing decreased atrial ERPs in all regions signiﬁcantly
(P < 0:05). However, in the presence of bepridil, atrial ERPs were
signiﬁcantly prolonged (P < 0:05).
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Figure 5 Eﬀect of bepridil serial MAPD90 changes during
rapid pacing and recovery period.
MAPD90 decreased gradually and recovered quickly in the
recovery period. Bepridil prolonged MAPD90 in all time courses
signiﬁcantly (P < 0:01).
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Figure 6 Inducibility of AF after rapid pacing with and
without bepridil.
The mean number of AF occurrences in the PBG was signiﬁcantly
fewer than in the PG. (2:1 2:4 vs. 8:5 7:0, p < 0:05)
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cantly higher than in the pacing only group. These
results may support the view that the blocking eﬀects
of both ICaL and ICaT of bepridil prevent the atrial
electrophysiological remodeling caused by rapid
pacing in the acute to even the mid phase.
Bepridil blocks also the slow components of
multiple Kþ currents such as the ultrarapid (Ikur),
rapid (Ikr), and slow delayed rectiﬁer current (Iks).
20)
The Ikur was speciﬁcally blocked by bepridil,
concentration-dependent, but not amiodarone.18)
Yamashita et al. reported that the short-term rapid
atrial pacing could increase transiently Kv1.5 gene
expression encodes Ikur.
21) Accordingly, bepridil may
prevent electrical remodeling to suppress this phe-
nomenon. Furthermore, suppressing not only Ikur but
also Ikr, bepridil may force atrial action potential
prolongation and display anti-arrhythmic eﬀects.
Thus, these ion-channels blocking eﬀects of
bepridil may also be closely related to the prevention
of electrical remodeling in clinical situations.
Regional Effects of Bepridil
We evaluated the regional diﬀerences in the eﬀect
of bepridil and rapid pacing on the ERP. Although
there is a signiﬁcant prolongation of the ERP in only
the RAA before rapid pacing by bepridil, it sup-
pressed the rapid-pacing-induced ERP shortening in
the RAFW and LAFW more than in the RAA. These
results suggest that the eﬀect of bepridil and ERP
shortening induced by rapid pacing was regionally
heterogeneous. Fukaya et al. reported that the mRNA
downregulation of L-type Ca2þ channel and SCN5A
caused by rapid atrial stimulation in dogs were
negated by bepridil in the RA; but not in the LA.22)
Although the mechanism of this heterogeneity was
unclear, the regional diﬀerences in the mechanical
stretch during rapid pacing may play an important
role. Fareh et al. reported that tachycardia-induced
ERP remodeling that plays an important role in
increasing atrial vulnerability to AF is spatially
nonuniform.23) Nevertheless, bepridil eventually sup-
pressed the inducibility and incidence of AF in this
rapid pacing pig model.
Study Limitations
The ﬁrst limitation is that we did not adjust the
ventricular response during atrial rapid pacing.
Therefore rapid ventricular response may aﬀect the
hemodynamics and electrophysiological character-
istics of the atrium. The second limitation is that we
could not evaluate the hemodynamic factors such as
systemic blood pressure and atrial pressure. Lastly,
the operation under pentobarbital anesthesia and
bleeding modiﬁed the autonomic nerve tone in the
experimental model.
Conclusion
Bepridil prevented the shortening of the ERP and
MAPD90 induced by rapid atrial pacing and subse-
quent incidence of AF in the acute phase. The results
of this study might explain the eﬃcacy of bepridil
for preventing the recurrence of paroxysmal AF.
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